We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+19.78%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$45.9B
AUM Growth
+$5.92B
(+15%)
Cap. Flow
-$190M
Cap. Flow
% of AUM
-0.41%
Top 10 Holdings %
Top 10 Hldgs %
24.37%
Holding
916
New
168
Increased
229
Reduced
363
Closed
115
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$338M |
| 2 |
ExxonMobil
XOM
|
+$291M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$271M |
| 4 |
GE Aerospace
GE
|
+$205M |
| 5 |
Emerson Electric
EMR
|
+$157M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$310M |
| 2 |
Sensata Technologies
ST
|
+$251M |
| 3 |
Fortive
FTV
|
+$226M |
| 4 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
+$117M |
| 5 |
Honeywell
HON
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.79% |
| 2 | Healthcare | 18.35% |
| 3 | Consumer Discretionary | 12.96% |
| 4 | Financials | 12.38% |
| 5 | Communication Services | 8.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VLTA
476
DELISTED
Volta Inc.
VLTA
| $16M | 0.03% |
+1,500,000
| New | +$15.7M |
|
|
IMGN
477
DELISTED
Immunogen Inc
IMGN
| $16M | 0.03% |
+2,475,000
| New | +$14.4M |
|
|
PSTX
478
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $15.9M | 0.03% |
1,450,268
+100,000
| +7% | +$1.05M |
|
|
LEAP.U
479
DELISTED
Ribbit LEAP, Ltd. Units, each consisting of one Class A Ordinary Share, and one fifth of one Warrant
LEAP.U
| $15.9M | 0.03% |
1,060,367
+60,367
| +6% | +$763K |
|
480
Western Digital
WDC
$150B
| $15.8M | 0.03% |
377,765
+18,522
| +5% | +$615K |
|
481
Gartner
IT
$11.7B
| $15.7M | 0.03% |
98,200
-200
| -0.2% | -$28.8K |
|
482
Domino's
DPZ
$11.6B
| $15.7M | 0.03% |
40,973
-1,600
| -4% | -$629K |
|
483
Brown-Forman Class B
BF.B
$13.1B
| $15.7M | 0.03% |
197,732
-7,700
| -4% | -$594K |
|
484
Lockheed Martin
LMT
$136B
| $15.6M | 0.03% |
43,939
+10,154
| +30% | +$3.73M |
|
485
Masco
MAS
$15.3B
| $15.5M | 0.03% |
282,300
+89,000
| +46% | +$4.9M |
|
|
SCOAU
486
DELISTED
ScION Tech Growth I Unit
SCOAU
| $15.5M | 0.03% |
+1,500,000
| New | +$15.5M |
|
487
NVR
NVR
$17B
| $15.5M | 0.03% |
3,792
-100
| -3% | -$416K |
|
|
GRTX
488
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
| $15.4M | 0.03% |
1,509,500
| – | – |
|
489
Semtech
SMTC
$13B
| $15.4M | 0.03% |
213,740
-374,387
| -64% | -$23.9M |
|
490
International Flavors & Fragrances
IFF
$21.9B
| $15.4M | 0.03% |
141,496
+32,500
| +30% | +$3.65M |
|
491
Jacobs Solutions
J
$17B
| $15.4M | 0.03% |
170,495
-7,496
| -4% | -$635K |
|
492
United Airlines
UAL
$42.1B
| $15.3M | 0.03% |
354,518
+40,209
| +13% | +$1.63M |
|
493
Arch Capital
ACGL
$33.6B
| $15.3M | 0.03% |
+425,000
| New | +$14M |
|
|
FPRX
494
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $15.3M | 0.03% |
+900,000
| New | +$11.3M |
|
|
NARI
495
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $15.3M | 0.03% |
175,000
+100,000
| +133% | +$7.06M |
|
496
Alaska Air
ALK
$5.58B
| $15.3M | 0.03% |
293,540
+158,540
| +117% | +$7.13M |
|
497
Talos Energy
TALO
$2.4B
| $15.2M | 0.03% |
+1,842,072
| New | +$14.3M |
|
|
TIF
498
DELISTED
Tiffany & Co.
TIF
| $15.1M | 0.03% |
114,754
-4,600
| -4% | -$589K |
|
499
Conagra Brands
CAG
$7.23B
| $15.1M | 0.03% |
415,745
-117,900
| -22% | -$4.28M |
|
500
Royal Caribbean
RCL
$85.6B
| $15M | 0.03% |
200,900
+1,400
| +0.7% | +$97.6K |
|
Similar funds
Adage Capital Partners's Q4 2020 Portfolio in Review
As of Q4 2020, Adage Capital Partners held 916 positions worth $45.9B, up 15% from $39.9B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Adage Capital Partners's Q4 2020 filing shows 168 new, 229 increased, 363 reduced and 115 closed positions. Its largest new stake was Tesla: 1,978,500 shares worth $465M. The largest sale was Royalty Pharma, an estimated $310M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Adage Capital Partners's largest Q4 2020 buy was Tesla: 1,978,500 shares worth $465M.
- Adage Capital Partners added most to ExxonMobil in Q4 2020, an estimated $291M increase.
- Adage Capital Partners's biggest Q4 2020 reduction was Royalty Pharma, cutting an estimated $310M.
- Adage Capital Partners fully exited Sensata Technologies in Q4 2020, selling an estimated $251M.
- Adage Capital Partners's ten largest holdings make up 24% of its $45.9B portfolio in Q4 2020.
- Adage Capital Partners opened 168 new positions and closed 115 in Q4 2020.
- Adage Capital Partners's portfolio value rose 15% quarter-over-quarter to $45.9B.
Based on Adage Capital Partners's 13F filing for Q4 2020, filed 16 Feb 2021.